About Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Daiichi Sankyo, Inc.
1
Clinical Trials at Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii
During the past decade, Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer
2008-12-01
2012-08-01
Completed
111
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2010-01-01
2015-12-01
Completed
1,069
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2009-09-01
2016-01-01
Completed
347
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii
According to Clinical.Site data, the most researched conditions in "Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii" are
"Carcinoma, Non-Small-Cell Lung" (2 trials) and "Metastatic Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii" in a lesser frequency.
Clinical Trials Intervention Types at Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii
Most popular intervention types in "Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "PF-02341066" (2 trials), "CS7017 tablets" (1 trials), "Carboplatin" (1 trials), "Docetaxel" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii
The vast majority of trials in "Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii" are
3 trials for "All" genders.
Clinical Trials Status at Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii
Currently, there are NaN active trials in "Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".